PRE

Prenetics Global Ltd

Nasdaq· Laboratory Analytical Instruments· Inc. E9· CIK 0001876431 Industrials & Manufacturing

$18.37 +1.02 (+5.88%)

Oct 26 4:00 PM ET · prev $17.35

Market cap

$280.7M

Micro cap

Consensus

Buy

89% Buy or better · 9 analysts

Median target

🔒 Subscribers only

Next earnings

Nov 9

in 13 days

1 year

+40.4%

from $13.08 · Oct 27

30 days

−19.3%

from $22.76

52-week range

$11.79–26.25

−30% from high · low Nov 17

Avg volume 20D

194.1K

Oct 8 spike 509.6K

Short interest

🔒 Subscribers only

Insider net

+$999.7K

2 buyers · 0 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BULLISH 12 reports · 90 days

Balance 0 bearish · 7 bullish · 5 neutral oldest → newest, height = score

Avg score

·High conf. 10/12 ·Next Earnings date, Nov 9, 2026

Strongest BULLISH Prenetics Global Ltd announced a multi-year collaboration with the NBA making its IM8 brand the Official…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Jul 14 Prenetics Global Ltd announced the closing of a $1 billion non-dilut…
R Aug 7 Prenetics Global Limited filed the full Customer Investment Agreemen…
R Aug 18 Prenetics Global (PRE) reported Q2 2026 total revenue of $46.5M (+28…
R Aug 18 Prenetics Q2 2026 revenue surged ~288% YoY to $46.5M, driven by its…
B Aug 20 to Aug 25 3 days of insider buys: $999.7K by 2 insiders, avg $20.92
R Aug 20 Prenetics Global Ltd (PRE) announced a multi-year global partnership…
R Aug 26 Prenetics CEO Danny Yeung and CFO Brian Rosin purchased $1.0M of PRE…
A Oct 12 Lucid Capital Markets initiates

Signal stack

Where each data set points today.

InsidersBULLISH

2 insiders bought $999.7K at an average $20.92. No open-market sales. Price is 12% below their cost.
InstitutionsMIXED

Q2 2026: 4 added (0 new), 4 trimmed or exited.
AnalystsBULLISH

8 of 9 rate it Buy or better.
TrendDOWNTREND

17% below its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
JANE STREET GROUP, LLC	DOUBLED	225,093	$4.3M
MILLENNIUM MANAGEMENT LLC	TRIM	126,086	$2.4M
MARSHALL WACE, LLP	TRIM	47,327	$904.9K
NOMURA HOLDINGS INC	TRIM	42,101	$805.0K
UBS Group AG	ADD	37,040	$708.2K
MORGAN STANLEY	ADD	23,443	$448.2K
WELLS FARGO & COMPANY/MN	NEAR_EXIT	10,000	$191.2K
SIMPLEX TRADING, LLC	DOUBLED	773	$14.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts

Buy 89% rate it Buy or better

Strong Buy1Buy7Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Recent actions

Date	Firm	Action	Rating
Oct 26, 2026	🔒 Fresh data, subscribers only INITIATE	INITIATE
Oct 12, 2026	Lucid Capital Markets INITIATE	INITIATE	Buy
Sep 17, 2026	Craig-Hallum INITIATE	INITIATE	Buy
Aug 27, 2026	B. Riley Securities INITIATE	INITIATE	Buy
Jul 15, 2026	Benchmark MAINTAIN	MAINTAIN	Buy
Jun 16, 2026	Benchmark INITIATE	INITIATE	Buy

Insider ledger

Form 4

$999.7K

bought · 2 insiders

sold · 0 insiders

−12.2%

vs their $20.92 cost

Date	Insider	Type	Value
Oct 4, 2026	Leogrande Hudson Blake Director	EXERCISE	2,000 sh
Sep 30, 2026	Lo Hoi Chun Chief Financial Officer	EXERCISE	7,635 sh
Sep 4, 2026	Leogrande Hudson Blake Director	EXERCISE	2,000 sh
Sep 3, 2026	Tat Thuan Yen VP, Finance of IM8 (US) LLC	AWARD	10,730 sh
Aug 25, 2026	Rosin Brian J CFO of IM8 (US) LLC	BUY	$116.3K
Aug 24, 2026	Rosin Brian J CFO of IM8 (US) LLC	BUY	$381.4K
Aug 24, 2026	Yeung Danny Sheng Wu Chief Executive Officer	BUY	$125.4K
Aug 24, 2026	Yeung Danny Sheng Wu Chief Executive Officer	BUY	$239.3K

Earnings setup

Estimates

Nov 9

reports in 13 days

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026

🔒 Subscribers only

shares short

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 13, 2026 SEC

Prenetics Global Ltd announced a multi-year collaboration with the NBA making its IM8 brand the Official Nutrition…

6-K — Impact 5/10

Oct 4, 2026 Insider

Leogrande Hudson Blake acquired via exercise 2,000 shares

Director

Sep 30, 2026 Insider

Lo Hoi Chun acquired via exercise 7,635 shares

Chief Financial Officer

Sep 22, 2026 SEC

Prenetics Global Ltd filed Pre-Effective Amendment No. 3 to its F-1 registration statement, solely to add auditor…

F-1/A — Impact 3/10

Sep 4, 2026 Insider

Leogrande Hudson Blake acquired via exercise 2,000 shares

Director

Aug 26, 2026 SEC

Caroline S. Levy filed a Form 3 initial statement of beneficial ownership, reporting 7,595 restricted stock units…

3 — Impact 2/10

Aug 18, 2026 Earnings

Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond

Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $2

Jun 30, 2026 Inst.

JANE STREET GROUP, LLC — DOUBLED

225,093 shares ($4.3M)

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Upcoming

Nov 9, 2026

Earnings date

PRE Q3 2026 Earnings Scheduled — 2026-11-09

Recent

Aug 18, 2026